Oaklins’ team in Los Angeles has advised the shareholders of Ambry Genetics Corporation, a clinical diagnostics testing services provider, on the sale of the company to Konica Minolta, Inc.
This powerful combination will bring the most comprehensive genetic diagnostic solutions to Japan, Europe and globally.
Read more about the transaction, market trends, deal drivers and M&A valuation aspects.
© Oaklins. All rights reserved. Oaklins refers to Oaklins International Inc. and/or one of its member firms, each of which is a separate legal entity. Please see www.oaklins.com/legal for further details.